HomeClinics HomeAbout ClinicsAll ClinicsHot TopicsAdvancesSpecial OffersCME
Logo
Search for

Volume 37, Issue 2, Pages 363-374 (June 2008)


View previous. 8 of 19 View next.

Dysregulated RET Signaling in Thyroid Cancer

Maria Domenica Castellone, MD, PhDa, Massimo Santoro, MD, PhDbCorresponding Author Informationemail address

Numerous biologic processes and such diseases as cancer depend on activation of tyrosine kinase receptors. The RET tyrosine kinase receptor was discovered two decades ago as a transforming gene and was subsequently implicated in the formation of papillary and medullary thyroid carcinoma. This article examines the data about the mechanism of activation of downstream signal transduction pathways by RET oncoproteins. Collectively, these findings have advanced the understanding of the processes underlying thyroid carcinoma formation.

a Istituto di Endocrinologia ed Oncologia Sperimentale del CNR “G.Salvatore”, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università di Napoli Federico II, via S. Pansini 5, 80131 Naples, Italy

b Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università di Napoli Federico II, via S. Pansini 5, 80131 Naples, Italy

Corresponding Author InformationCorresponding author.

 The authors apologize to the many colleagues whose work could not be cited because of space limitations. This study was supported by the Italian Association for Cancer Research.

PII: S0889-8529(08)00010-8

doi:10.1016/j.ecl.2008.02.006


View previous. 8 of 19 View next.